Application of intrathecal trastuzumab (Herceptintrade mark) for treatment of meningeal carcinomatosis in HER2-overexpressing metastatic breast cancer. (Q48593345)
Jump to navigation
Jump to search
scientific article published in May 2006
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Application of intrathecal trastuzumab (Herceptintrade mark) for treatment of meningeal carcinomatosis in HER2-overexpressing metastatic breast cancer. |
scientific article published in May 2006 |
Statements
Application of intrathecal trastuzumab (Herceptintrade mark) for treatment of meningeal carcinomatosis in HER2-overexpressing metastatic breast cancer (English)
H J Stemmler
M Schmitt
N Harbeck
A Willems
H Bernhard
D Lässig
S Schoenberg